JPS6467199A - Human igg1 type monoclonal antibody, production thereof and hybridoma capable of producing said antibody - Google Patents

Human igg1 type monoclonal antibody, production thereof and hybridoma capable of producing said antibody

Info

Publication number
JPS6467199A
JPS6467199A JP62223174A JP22317487A JPS6467199A JP S6467199 A JPS6467199 A JP S6467199A JP 62223174 A JP62223174 A JP 62223174A JP 22317487 A JP22317487 A JP 22317487A JP S6467199 A JPS6467199 A JP S6467199A
Authority
JP
Japan
Prior art keywords
igg1 type
antibody
monoclonal antibody
human igg1
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62223174A
Other languages
English (en)
Other versions
JPH0695949B2 (ja
Inventor
Masao Tanihara
Hideaki Yamada
Toshihide Nakajima
Sukeaki Omura
Koichi Takakura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
Agency of Industrial Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency of Industrial Science and Technology filed Critical Agency of Industrial Science and Technology
Priority to JP62223174A priority Critical patent/JPH0695949B2/ja
Priority to US07/175,304 priority patent/US5192684A/en
Publication of JPS6467199A publication Critical patent/JPS6467199A/ja
Priority to JP3208955A priority patent/JPH0771484B2/ja
Publication of JPH0695949B2 publication Critical patent/JPH0695949B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/286Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against neuromediator receptors, e.g. serotonin receptor, dopamine receptor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP62223174A 1987-09-08 1987-09-08 ヒトIgG1型モノクローン抗体 Expired - Lifetime JPH0695949B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP62223174A JPH0695949B2 (ja) 1987-09-08 1987-09-08 ヒトIgG1型モノクローン抗体
US07/175,304 US5192684A (en) 1987-09-08 1988-03-30 Human IgG1 monoclonal antibody specific for the nicotinic acetylcholine receptor and hybridoma producing the antibody
JP3208955A JPH0771484B2 (ja) 1987-09-08 1991-07-26 新規なハイブリドーマ

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP62223174A JPH0695949B2 (ja) 1987-09-08 1987-09-08 ヒトIgG1型モノクローン抗体
JP3208955A JPH0771484B2 (ja) 1987-09-08 1991-07-26 新規なハイブリドーマ

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP3208955A Division JPH0771484B2 (ja) 1987-09-08 1991-07-26 新規なハイブリドーマ

Publications (2)

Publication Number Publication Date
JPS6467199A true JPS6467199A (en) 1989-03-13
JPH0695949B2 JPH0695949B2 (ja) 1994-11-30

Family

ID=26517140

Family Applications (2)

Application Number Title Priority Date Filing Date
JP62223174A Expired - Lifetime JPH0695949B2 (ja) 1987-09-08 1987-09-08 ヒトIgG1型モノクローン抗体
JP3208955A Expired - Lifetime JPH0771484B2 (ja) 1987-09-08 1991-07-26 新規なハイブリドーマ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP3208955A Expired - Lifetime JPH0771484B2 (ja) 1987-09-08 1991-07-26 新規なハイブリドーマ

Country Status (2)

Country Link
US (1) US5192684A (ja)
JP (2) JPH0695949B2 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004257862A (ja) * 2003-02-26 2004-09-16 Akihiko Yano 重症筋無力症の検査方法及びそのための検査薬

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4129849A1 (de) * 1991-02-14 1992-08-27 Boehringer Mannheim Gmbh Monoklonale antikoerper gegen humane pankreas-inselzellen
US7105159B1 (en) 1992-11-05 2006-09-12 Sloan-Kettering Institute For Cancer Research Antibodies to prostate-specific membrane antigen
US20050215472A1 (en) * 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
AU2002356844C1 (en) * 2001-10-23 2010-03-04 Amgen Fremont Inc. PSMA antibodies and protein multimers
US7879913B2 (en) * 2005-06-28 2011-02-01 Catholic Healthcare West Iptakalim hydrochloride for decreasing nicotine use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58201723A (ja) * 1982-04-05 1983-11-24 ジエネテイツク・システムズ・コ−ポレイシヨン イムノグロブリンの製造方法
JPS58216125A (ja) * 1982-06-09 1983-12-15 Asahi Chem Ind Co Ltd ヒト抗体の産生方法
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト/ヒトハイブリド−マ及びその生産する抗体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59231024A (ja) * 1983-06-14 1984-12-25 Medekusu:Kk 自己免疫疾患に対する治療薬

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58201723A (ja) * 1982-04-05 1983-11-24 ジエネテイツク・システムズ・コ−ポレイシヨン イムノグロブリンの製造方法
JPS58216125A (ja) * 1982-06-09 1983-12-15 Asahi Chem Ind Co Ltd ヒト抗体の産生方法
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト/ヒトハイブリド−マ及びその生産する抗体

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004257862A (ja) * 2003-02-26 2004-09-16 Akihiko Yano 重症筋無力症の検査方法及びそのための検査薬

Also Published As

Publication number Publication date
JPH0771484B2 (ja) 1995-08-02
JPH0695949B2 (ja) 1994-11-30
US5192684A (en) 1993-03-09
JPH05304981A (ja) 1993-11-19

Similar Documents

Publication Publication Date Title
DE3070655D1 (en) Hybrid cell line for producing monoclonal antibody to a human prothymocyte antigen, antibody, method of preparation of this antibody, diagnostic and therapeutic uses, and pharmaceutical compositions comprising this antibody
DE3070896D1 (en) Monoclonal antibody to human helper t cells, method of preparing it, hybrid cell line producing it, its diagnostic and therapeutic uses and diagnostic and therapeutic compositions comprising it
YU45069B (en) Process of obtaining a monoclonal antibody
YU43913B (en) Process for obtaining hybride cell plant for making monoclonal antibodies
MY8600518A (en) Hybird cell line for producing monoclonal antibody to a human early thymocyte antigen antibody method of preparation of this antibody diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody
MY8600516A (en) Hybird cell lime for producing monoclonal antibody to human thymocyte antigen antibody method of preparation of this antibody diagnostic and therepeutic uses and pharmaceutical compositions comprising this antibody
JPS6467199A (en) Human igg1 type monoclonal antibody, production thereof and hybridoma capable of producing said antibody
JPS6468398A (en) Monoclonal anti-idiotype antibody and hybridoma and use thereof
JPS6451090A (en) Monoclonal antibody, production thereof and enzyme determining reagent comprising said antibody

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term